Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
3
×
Tags
clinical trials
fda
life sciences
national
3
×
national blog main
national top stories
new york top stories
san francisco top stories
biotech
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
europe top stories
gene therapy
indiana blog main
indiana top stories
new york blog main
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
alnylam pharmaceuticals
ambys medicines
amicus therapeutics
ampio pharmaceuticals
angelman syndrome
arena pharmaceuticals
athenex
billy dunn
biogen
What
drug
fda
3
×
patients
3
×
medicine
therapy
approved
aren’t
atrophy
bio
cancer
daily
developers
drugs
eisai
evrysdi
flags
friday
gene
green
help
higher
home
imminent
incidence
intended
lights
liquid
long
lorcaserin
loss
market
marketing
medicare
moves
muscular
new
news
noteworthy
oral
post
Language
unset
Current search:
photo
×
fda
×
patients
×
national
×
@xconomy.com
3 years ago
FDA Green-Lights Roche Spinal Muscular Atrophy Drug, First Oral Therapy
@xconomy.com
4 years ago
Eisai Pulls Weight Loss Drug From Market After FDA Flags Cancer Risks
@xconomy.com
5 years ago
Bio Roundup: Medicare Drug Prices, FDA Moves, Gene Therapy News & More
